Morgan Stanley’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-670,522
| Closed | -$50.5M | – | 8166 |
|
|
2022
Q2 | $50.5M | Buy |
670,522
+96,150
| +17% | +$7.24M | 0.01% | 1355 |
|
|
2022
Q1 | $15.4M | Buy |
574,372
+236,612
| +70% | +$6.35M | ﹤0.01% | 2402 |
|
|
2021
Q4 | $16.1M | Buy |
337,760
+297,357
| +736% | +$14.2M | ﹤0.01% | 2398 |
|
|
2021
Q3 | $2.69M | Sell |
40,403
-13,479
| -25% | -$896K | ﹤0.01% | 4326 |
|
|
2021
Q2 | $4.2M | Buy |
53,882
+46,909
| +673% | +$3.66M | ﹤0.01% | 3964 |
|
|
2021
Q1 | $660K | Sell |
6,973
-44,065
| -86% | -$4.17M | ﹤0.01% | 4992 |
|
|
2020
Q4 | $6.22M | Buy |
51,038
+41,571
| +439% | +$5.07M | ﹤0.01% | 3026 |
|
|
2020
Q3 | $827K | Sell |
9,467
-3,743
| -28% | -$327K | ﹤0.01% | 4344 |
|
|
2020
Q2 | $853K | Buy |
13,210
+9,922
| +302% | +$641K | ﹤0.01% | 4282 |
|
|
2020
Q1 | $147K | Sell |
3,288
-35,390
| -91% | -$1.58M | ﹤0.01% | 5015 |
|
|
2019
Q4 | $2.41M | Buy |
38,678
+30,342
| +364% | +$1.89M | ﹤0.01% | 3891 |
|
|
2019
Q3 | $314K | Buy |
8,336
+8,221
| +7,149% | +$310K | ﹤0.01% | 4910 |
|
|
2019
Q2 | $5K | Buy |
+115
| New | +$5K | ﹤0.01% | 6327 |
|